Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammatory Response and Anti-inflammatory Action for Aortopathy & Arteriopathy (5A-Plan): A Multicenter Cohort Study

NCT04918108 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT04918108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04918108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammatory Response and Anti-inflammatory Action for Aortopathy & Arteriopathy (5A-Plan): A Multicenter Cohort Study
Lead sponsor
Nanjing Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
August 30, 2021
Enrollment
2,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic dissection